Prakash Achaary

MMS Strengthens Science-Led Global Leadership, Naming Ben Dudley as President 

(CANTON, MICHIGAN and LONDON). MMS Holdings, a global, data-focused clinical research organization (CRO), today named UK-based Ben Dudley as President, extending his existing role as Chief Commercial Officer. The expanded position further supports MMS’ vision and growth as a science-led CRO, helping sponsors worldwide navigate complexity, reduce risk, and advance clinical programs through its integrated biometrics and regulatory capabilities. Dudley’s appointment reinforces MMS’ increasing international presence and builds on strong recent momentum in Europe, including the 2025 MMS Strengthens Science-Led Global Leadership, Naming Ben Dudley as President 

Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

CANTON, Mich. (January 29, 2026) – MMS, a global, data-focused clinical research organization (CRO), today announced it has been named a finalist in the 2026 Association for Clinical Data Management (ACDM) Awards for Innovation in the Management of Clinical Data in recognition of Datacise®, its secure, cloud-based clinical data science platform.  The finalist designation recognizes Datacise for its ability to help pharmaceutical and biotech companies make faster, more Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

Former FDA, CRO, and Industry Leader Dr. Stephine Keeton Joins MMS as Senior Director of Biometrics 

CANTON, Mich. (December 4, 2025) – MMS, a global, data-focused clinical research organization (CRO), announced today that Stephine Keeton, PhD, has joined the company as Senior Director of Biometrics. Her appointment comes against an industry backdrop of rising trial and data complexity, alongside intensifying pressure on sponsors to accelerate cycle times and enhance productivity. With Former FDA, CRO, and Industry Leader Dr. Stephine Keeton Joins MMS as Senior Director of Biometrics 

MMS Brings Biometrics and AI Leadership to PHUSE EU Connect 2025 and Previews Accepted Presentations for US Connect 2026

CANTON, Mich. and HAMBURG (November 14, 2025) – MMS, a global, data-focused clinical research organization (CRO), is set to bring fresh insights and hands-on engagement to PHUSE EU Connect 2025, taking place in Hamburg, Germany, from November 16-19, 2025, at CCH – Congress Center Hamburg. James Zee, Director of Statistical Programming at MMS, will deliver MMS Brings Biometrics and AI Leadership to PHUSE EU Connect 2025 and Previews Accepted Presentations for US Connect 2026

MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform 

MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform 

CANTON, Mich. and BELFAST (October 16, 2025) – MMS, a global, data-focused clinical research organization (CRO), announced today that it has been named a finalist in the 2025 Fierce Innovation Awards: Life Sciences Edition for its clinical trial simulation platform, KerusCloud®. Recognized as one of the top solutions in the Data Analytics and Business Intelligence MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform 

MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion 

CANTON (June 19, 2025) – MMS, a global, data-focused clinical research organization (CRO), has been named the winner of the 2025 Fierce CRO Award in the category of Excellence in Client Service and Partnership and the company’s CEO Dr. Uma Sharma has earned the CRO Champion Award, which recognizes leaders whose vision and values have shaped the future MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion 

MMS REMS-focused Technology bolsters Full-Service REMS Solutions

REMS Solutions

CANTON, Mich. (March 19, 2025) – MMS, an award-winning, data-focused clinical research organization (CRO), is showcasing its expansion as a tech-enabled, full-service Risk Evaluation and Mitigation Strategies (REMS) solutions provider today during a presentation given by CEO Dr. Uma Sharma at the REMS Industry Consortium (RIC) Annual Meeting today in Arlington, Virginia. The integration of MMS REMS-focused Technology bolsters Full-Service REMS Solutions

MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO

KerusCloud and Exploristics

CANTON, Mich. (February 12, 2025) – MMS, an award-winning, data-focused clinical research organization (CRO), announced today its acquisition of Exploristics, a leading biostatistics and data science company based in Belfast, Northern Ireland. The acquisition will add the company’s flagship product, KerusCloud®, a state-of-the-art, cloud-based statistical modeling and simulation platform to MMS’ data-driven approach towards efficient MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO

AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium

AI in Pharma

The Biennial Scientific Symposium at MMS is a global opportunity to bring together leading minds from within the CRO and across the industry to explore the intersection of artificial intelligence (AI) in pharma, innovative trial designs, and leadership in a tech-enabled world. Over the course of four days, thought leaders, scientists, and industry experts shared AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

Top Workplace by Detroit Free Press for 2024

DETROIT (November 19, 2024) – MMS, a leading data and regulatory focused clinical research organization (CRO), today announced its recognition as a Top Workplace by the Detroit Free Press and the USA Today Network for the fourth consecutive year. This prestigious award is based entirely on employee feedback, highlighting the company’s unwavering commitment to fostering MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

CANTON, Mich. (November 8, 2024) – MMS, a leading data and regulatory focused clinical research organization (CRO), today announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance. The Fierce CRO Awards aim to recognize and celebrate the remarkable achievements of MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

CANTON, Mich. (October 15, 2024) – MMS, a leading data and regulatory focused clinical research organization (CRO), today announced that it has been awarded bronze medal status by EcoVadis, demonstrating its commitment to environmental, social, and governance (ESG) initiatives. Bronze medal status is earned by organizations that are in the top 35th  percentile globally when MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)